| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -5,013 | 100% | $9.29 | -$46,571 |
| Net | -5 | -5,013 | -100% | -$46,571 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Everett Rand Sutherland | Chief Executive Officer, Director | $677,306 | -$19,444 | -2.8% | 16 Mar 2026 |
| Aaron Deykin | Chief Medical Officer | $303,662 | -$8,305 | -2.7% | 16 Mar 2026 |
| Michael Gray | CFO and COO | $275,429 | -$7,915 | -2.8% | 16 Mar 2026 |
| Adam Houghton | Chief Business Officer | $225,756 | -$6,494 | -2.8% | 16 Mar 2026 |
| Allison Ambrose | General Counsel | $153,517 | -$4,413 | -2.8% | 16 Mar 2026 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10%+ Owner | 15 Oct 2024 | |||
| ORBIMED ADVISORS LLC | Director, 10%+ Owner | 15 Oct 2024 | |||
| Liam Ratcliffe | Director | 10 Jun 2025 | |||
| Marcella K. Ruddy | Director | 10 Jun 2025 | |||
| Daniella Beckman | Director | 10 Jun 2025 | |||
| AI Upstream LLC | 10%+ Owner | 15 Oct 2024 | |||
| Erez Chimovits | Director | 10 Jun 2025 | |||
| Harold Edward Fleming | Director | 10 Jun 2025 | |||
| Ronald C. Renaud Jr. | Director | 10 Jun 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michael Gray | UPB | Common Stock | Sale | -2.79% | $7,915 | $9.29 | -852 | 29,648 | 16 Mar 2026 | Direct |
| Aaron Deykin | UPB | Common Stock | Sale | -2.66% | $8,305 | $9.29 | -894 | 32,687 | 16 Mar 2026 | Direct |
| Everett Rand Sutherland | UPB | Common Stock | Sale | -2.79% | $19,444 | $9.29 | -2,093 | 72,907 | 16 Mar 2026 | Direct |
| Allison Ambrose | UPB | Common Stock | Sale | -2.79% | $4,413 | $9.29 | -475 | 16,525 | 16 Mar 2026 | Direct |
| Adam Houghton | UPB | Common Stock | Sale | -2.8% | $6,494 | $9.29 | -699 | 24,301 | 16 Mar 2026 | Direct |
| Michael Gray | UPB | Common Stock | Award | 30,500 | 30,500 | 02 Jan 2026 | Direct | |||
| Michael Gray | UPB | Stock Option (Right to Buy) | Award | 91,500 | 91,500 | 02 Jan 2026 | Direct | |||
| Aaron Deykin | UPB | Common Stock | Award | 2024% | 32,000 | 33,581 | 02 Jan 2026 | Direct | ||
| Aaron Deykin | UPB | Stock Option (Right to Buy) | Award | 96,000 | 96,000 | 02 Jan 2026 | Direct | |||
| Allison Ambrose | UPB | Common Stock | Award | 17,000 | 17,000 | 02 Jan 2026 | Direct | |||
| Allison Ambrose | UPB | Stock Option (Right to Buy) | Award | 51,000 | 51,000 | 02 Jan 2026 | Direct | |||
| Adam Houghton | UPB | Common Stock | Award | 25,000 | 25,000 | 02 Jan 2026 | Direct | |||
| Adam Houghton | UPB | Stock Option (Right to Buy) | Award | 75,000 | 75,000 | 02 Jan 2026 | Direct | |||
| Everett Rand Sutherland | UPB | Common Stock | Award | 75,000 | 75,000 | 02 Jan 2026 | Direct | |||
| Everett Rand Sutherland | UPB | Stock Option (Right to Buy) | Award | 225,000 | 225,000 | 02 Jan 2026 | Direct | |||
| Ronald C. Renaud Jr. | UPB | Stock Option (Right to Buy) | Award | 17,096 | 17,096 | 10 Jun 2025 | Direct | |||
| Erez Chimovits | UPB | Stock Option (Right to Buy) | Award | 17,096 | 17,096 | 10 Jun 2025 | Direct | |||
| Marcella K. Ruddy | UPB | Stock Option (Right to Buy) | Award | 17,096 | 17,096 | 10 Jun 2025 | Direct | |||
| Daniella Beckman | UPB | Stock Option (Right to Buy) | Award | 17,096 | 17,096 | 10 Jun 2025 | Direct | |||
| Harold Edward Fleming | UPB | Stock Option (Right to Buy) | Award | 17,096 | 17,096 | 10 Jun 2025 | Direct | |||
| Liam Ratcliffe | UPB | Stock Option (Right to Buy) | Award | 17,096 | 17,096 | 10 Jun 2025 | Direct |